Bone marrow microvessel density and its prognostic significance in AML

Area of Science:

• Hematology
• Oncology
• Transplantation

Background:

• Bone marrow microvessel density (BM-MVD) is elevated in hematologic disorders.
• Increased BM-MVD in acute leukemias is associated with unfavorable prognosis.

Purpose of the Study:

• To investigate the prognostic significance of BM-MVD in acute myeloid leukemia (AML) patients undergoing chemotherapy and allogeneic bone marrow transplantation (BMT).

Main Methods:

• Retrospective analysis of BM-MVD at diagnosis in 31 AML patients.
• Comparison of BM-MVD between AML patients and controls.
• Correlation of BM-MVD with remission rates, survival, and relapse risk.
• Assessment of BM-MVD changes post-BMT.

Main Results:

• AML patients exhibited significantly higher BM-MVD than controls (median 30/mm² vs. 7/mm²).
• Higher BM-MVD at diagnosis was associated with failure to achieve complete remission (CR) (median 41.5/mm² vs. 28.5/mm²).
• Elevated BM-MVD (>30 mm²) correlated with shorter overall survival and increased relapse risk.
• BM-MVD decreased significantly by day 100 post-BMT in patients achieving continuous CR.

Conclusions:

• BM-MVD at diagnosis is a significant prognostic factor for survival in AML patients undergoing allogeneic BMT.
• Decreased BM-MVD post-BMT indicates a positive response to treatment.
• BM-MVD holds potential as a predictive biomarker in AML treatment strategies.